Guobing S. Li
Chongqing, 400037, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Self-assembled manganese-based nanoplatforms synergizing immunogenic cell death and STING activation for triple-negative breast cancer.
Journal: Materials today. Bio
Published: February 01, 2026
Supramolecular Assembly of Stepped-Persistent ROS Nanogenerator for Sustained Tumor Immunotherapy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 22, 2026
Gypenosides inhibit melanoma proliferation, migration and enhance the anti-tumor immunity of CD8+ T cells via ETV5/PD-L1 signaling.
Journal: Journal of translational medicine
Published: December 11, 2025
Blocking PCSK9 suppresses hepatocellular carcinoma immune escape by decreasing FLI1-mediated SPP1 and PD-L1 expression.
Journal: Journal for immunotherapy of cancer
Published: November 07, 2025
Engineered Cryo-Shocked Cancer Cells Deliver Dual-Function Gene Medicines for Melanoma Immunotherapy.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: August 08, 2025
CREB binding protein (CREBBP): Structure-based perspectives for the development of clinical inhibitors.
Journal: Translational oncology
Published: May 20, 2025
Risk factors for adverse prognosis in acute aortic syndrome: a single-center retrospective cohort study
Journal: Zhonghua xin xue guan bing za zhi
Published: February 18, 2025
L-methionine promotes CD8+ T cells killing hepatocellular carcinoma by inhibiting NR1I2/PCSK9 signaling.
Journal: Neoplasia (New York, N.Y.)
Published: October 23, 2024
Artesunate induces melanoma cell ferroptosis and augments antitumor immunity through targeting Ido1.
Artesunate induces melanoma cell ferroptosis and augments antitumor immunity through targeting Ido1.
Journal: Cell communication and signaling : CCS
Published: June 11, 2024
The immunosuppressive landscape in tumor microenvironment.
Journal: Immunologic research
Published: December 28, 2023
Nanoparticle-mediated celastrol ER targeting delivery amplify immunogenic cell death in melanoma.
Journal: Journal of advanced research
Published: December 14, 2023
Tozasertib activates anti-tumor immunity through decreasing regulatory T cells in melanoma.
Journal: Neoplasia (New York, N.Y.)
Published: November 13, 2023
Last Updated: 09/26/2026